A Washington D.C.-based biotech is causing quite the stir so far during Wednesday’s premarket after the company’s Fanapt received FDA approval for the acute treatment...

To read the full story on AllPennyStocks.com, click here.

Vanda Pharmaceuticals (NASDAQ:VNDA)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024 Plus de graphiques de la Bourse Vanda Pharmaceuticals
Vanda Pharmaceuticals (NASDAQ:VNDA)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024 Plus de graphiques de la Bourse Vanda Pharmaceuticals